Injectable Drug Delivery Market - Global Forecast to 2026, by Device Type (Prefilled Syringes, Auto Injectors, Pens, Conventional Syringes, Cartridges, Ampoules, Vials, and Others), by Material Type (Glass and Plastic), by Usability (Disposable and Reusable), by Route of Administration (Intravenous, Intramuscular, and Subcutaneous), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

  • Published On : Jun 2019 |
  • Pages : 262 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global Injectable Drug Delivery Market – Market Insights

Injectable drug delivery is considered as the most effective route of administration for the effective delivery of drugs to the targeted site, which enhances the patient’s compliance to the drug. The Injectable delivery enhances the rapid absorption of drug from various sites such as subcutaneous, intravenous, and intramuscular. The injectable delivery increases the bioavailability of the drug at the systemic circulation, which offers availability of drug at intended site of action. 

The global injectable drug delivery market size was valued at US$ 15,939.0 million in 2017, and is expected to exhibit a CAGR of 8.3% over the forecast period (2018 – 2026).

Figure 1. Global Injectable Drug Delivery Market Value (US$ Mn), by Region, 2017

Injectable Drug Delivery  | Coherent Market Insights

                                                                    Source: Coherent Market Insights Analysis (2019)

 

Increasing prevalence of chronic diseases such as diabetes and anaphylaxis is expected to propel growth of the global injectable drug delivery market

Increasing prevalence of chronic diseases such as diabetes and other diseases is expected to drive the market growth. According to the World Health Organization (WHO), in November 2011, around 60 million people in Europe suffered from diabetes, of which around 10.3% were men and 9.6% were women aged 25 years and above. Similarly, according to World Health Organization (WHO) 2018 factsheet, around 8.5% adults aged 18 years and above had diabetes in 2014 globally.

Moreover, the market players are focused on product development and launch of injectors, which is expected to propel growth of the global injectable drug delivery market over the forecast period. For instance, in 2016, Berlin-Chemie launched BerliPen areo 3 in Germany. BerliPen areo 3 is a 300 unit insulin pen, which can be used with six different insulins in the treatment of type 1 and 2 diabetes. Similarly, in August 2018, Teva Pharmaceuticals received the U.S. Food and Drug Administration (FDA) approval for generic version of Mylan’s EpiPen and EpiPen Jr. Teva Pharmaceuticals is the first generic manufacturer that received the FDA approval.

However, increasing product recalls is expected to hinder the market growth. In December 2012, Bracco Diagnostics Inc., initiated a Class I recall of nine lots of Isovue Pre-Filled Power Injector Syringes, which are to be used with Stellant CT Injection Systems, due to presence of visible particles in syringes observed at the end of standard stability studies on retained samples, according to the U.S. Food and Drug Administration (FDA)

Figure 2. Global Injectable Drug Delivery Market Share (%), by Usability,2018 and 20   Injectable Drug Delivery  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing product approval and launch in North America is expected to bolster the market growth

North America holds dominant position in the global injectable drug delivery market, owing to increased focus of regional players in research and development and product launches. In 2017, Bayer received U.S. Food and Drug Administration (FDA) approval for a connected auto-injector-BETACONNECT for relapsing-remitting multiple sclerosis medication and companion app- myBETAapp. The app allows patients to automatically have a record of all their injections and share that record with their nurse or physician. Similarly, in October 2018, Genentech announced the U.S. Food and Drug Administration (FDA) approval for single-dose prefilled syringes (PFS) for Xolair (omalizumab) as an additional formulation for both allergic asthma and chronic idiopathic urticaria (CIU) indications.

Moreover, increasing incidence of chronic diseases such as anaphylaxis, diabetes, and cardiac arrest in the region is expected to support growth of the market during the forecast period. For instance, according to Journal of Allergy and Clinical Immunology, 2014, prevalence of anaphylaxis in the U.S. was 1.6% in the general population, while the number of hospitalizations associated with the disease is ever increasing in the U.S.

Furthermore, increasing initiatives by companies to make auto-injectors available to patients suffering from anaphylaxis is expected to boost global injectable drug delivery market. For instance, Mylan N.V. provides discount cards to epinephrine buyers, and offers discounts up to US$ 300 on branded version of EpiPen and up to US$ 25 on the approved generic version of EpiPen.

Key Players

Major players operating in the global injectable drug delivery market include Becton, Dickinson and Company, Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-Zeiss-Stiftung, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group, Owen Mumford Limited, and Injex Pharma GmbH

Injectables offer maximum bioavailability of drugs towards the intended site of action and avoid the first pass metabolism. The injectable route is mostly preferred for the drugs which can’t be taken orally or have some stability problems. Unconscious patients or patients having low compliance towards oral tablets or capsules can be preferred for the injectable drug delivery therapy.

Market Dynamics

Increasing prevalence of chronic diseases such as diabetes, cardiac diseases, and anaphylaxis has supported growth of global injectable drug delivery market. According to the Allergy, Asthma & Clinical Immunology, in 2015, around 15 million people suffered from food allergies in the U.K. Similarly, according to the European Academy of Allergy and Clinical Immunology (EAACI), in 2015, around 17 million people suffered from food allergies in the U.K., of which around 3.5 million were children. Increasing awareness regarding safety and concern of needlestick injuries is a major factor driving growth of the injectable drug delivery market. For instance, the WHO recommended the use of safety syringes with sharp injury protection (SIP), in order to prevent needlestick injuries. Similarly, in May 2017, Innovative Neurons LLC announced to commercialize its patented auto retractable multi-needle syringe known as FAST (fast, accessible, safe, and technology) to decrease needlestick injuries. Various market players are focusing on the development and advancement in this space. For instance, ACT-O-VIAL System offered by Pfizer Inc. is a dual-component vial system that allows reconstitution of sterile, injectable medications by pressing on the plastic cap. The facility launch by market players to cater requirements of patients is expected to drive the market growth. For instance, in July 2018, Pfizer, Inc. announced to build sterile injectable pharmaceutical production facilities in the Michigan, U.S.

However, product recalls by the manufacturers is the major factors restraining the market over the forecast period. For instance, in April 2018, Becton Dickson and Company announced a recall of PosiFlush Heaparin Lock Flush Syringe, and Prefilled normal saline syringe, owing to the contamination with Serratia marcescens bacterium.

Key features of the study:

  • This report provides in-depth analysis of the injectables drug delivery market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global injectable drug delivery market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Becton, Dickinson and Company, Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-Zeiss-Stiftung, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group, Owen Mumford Limited, Injex Pharma GmbH.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global injectables drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injectable drug delivery market

Detailed Segmentation:

  • Global Injectable Drug Delivery Market, By Device Type:
    • Prefilled Syringes
    • Auto Injectors
    • Pens
    • Conventional Syringes
    • Cartridges
    • Ampoules
    • Vials
    • Others
  • Global Injectable Drug Delivery Market, By Material Type:
    • Glass
    • Plastic
  • Global Injectable Drug Delivery Market, By Usability:
    • Disposable
    • Reusable
  • Global Injectable Drug Delivery Market, By Route of Administration:
    • Intravenous
    • Intramuscular
    • Subcutaneous
  • Global Injectable Drug Delivery Market, By End User:
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Home Care Settings
    • Others
  • Global Injectable Drug Delivery Market, By Region:
    • North America
      • By Device Type:
        • Prefilled Syringes
        • Auto Injectors
        • Pens
        • Conventional Syringes
        • Cartridges
        • Ampoules
        • Vials
        • Others
      • By Material Type:
        • Glass
        • Plastic
      • By Usability:
        • Disposable
        • Reusable
      • By Route of Administration:
        • Intravenous
        • Intramuscular
        • Subcutaneous
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Home Care Settings
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Device Type:
        • Prefilled Syringes
        • Auto Injectors
        • Pens
        • Conventional Syringes
        • Cartridges
        • Ampoules
        • Vials
        • Others
      • By Material Type:
        • Glass
        • Plastic
      • By Usability:
        • Disposable
        • Reusable
      • By Route of Administration:
        • Intravenous
        • Intramuscular
        • Subcutaneous
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Home Care Settings
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Device Type:
        • Prefilled Syringes
        • Auto Injectors
        • Pens
        • Conventional Syringes
        • Cartridges
        • Ampoules
        • Vials
        • Others
      • By Material Type:
        • Glass
        • Plastic
      • By Usability:
        • Disposable
        • Reusable
      • By Route of Administration:
        • Intravenous
        • Intramuscular
        • Subcutaneous
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Home Care Settings
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Device Type:
        • Prefilled Syringes
        • Auto Injectors
        • Pens
        • Conventional Syringes
        • Cartridges
        • Ampoules
        • Vials
        • Others
      • By Material Type:
        • Glass
        • Plastic
      • By Usability:
        • Disposable
        • Reusable
      • By Route of Administration:
        • Intravenous
        • Intramuscular
        • Subcutaneous
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Home Care Settings
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Device Type:
        • Prefilled Syringes
        • Auto Injectors
        • Pens
        • Conventional Syringes
        • Cartridges
        • Ampoules
        • Vials
        • Others
      • By Material Type:
        • Glass
        • Plastic
      • By Usability:
        • Disposable
        • Reusable
      • By Route of Administration:
        • Intravenous
        • Intramuscular
        • Subcutaneous
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Home Care Settings
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Device Type:
        • Prefilled Syringes
        • Auto Injectors
        • Pens
        • Conventional Syringes
        • Cartridges
        • Ampoules
        • Vials
        • Others
      • By Material Type:
        • Glass
        • Plastic
      • By Usability:
        • Disposable
        • Reusable
      • By Route of Administration:
        • Intravenous
        • Intramuscular
        • Subcutaneous
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Home Care Settings
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Becton, Dickinson and Company*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Pfizer Inc.
    • Novo Nordisk A/S
    • Gerresheimer AG
    • Carl-Zeiss-Stiftung
    • Terumo Corporation
    • Vetter Pharma-Fertigung GmbH & Co. KG
    • SHL Group
    • Owen Mumford Limited
    • Injex Pharma GmbH

 “*” marked represents similar segmentation in other categories in the respective section

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Device Type
      • Market Snippet, By Material Type
      • Market Snippet, By Usability
      • Market Snippet, By Route of Administration
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Scenario
    • PEST Analysis
    • Partnership and Acquisition Scenario
    • Recent Product Launches/Approvals
    • Technological Evolution
    • Market Trends
  4. Global Injectable Drug Delivery Market, By Device Type, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Prefilled Syringes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Auto Injectors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Pens
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Conventional Syringes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Cartridges
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Ampoules
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Vials
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  5. Global Injectable Drug Delivery Market, By Material Type, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Glass
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Plastic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  6. Global Injectable Drug Delivery Market, By Usability, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Disposable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Reusable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  7. Global Injectable Drug Delivery Market, By Route of Administration, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Intravenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Intramuscular
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Subcutaneous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  8. Global Injectable Drug Delivery Market, By End User, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Home Care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  9. Global Injectable Drug Delivery Market, By Region, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Germany
        • U.K.
        • France        
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  10. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Becton, Dickinson and Company
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Pfizer Inc.
        •  Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novo Nordisk A/S
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Gerresheimer AG
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Carl-Zeiss-Stiftung
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Terumo Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Vetter Pharma-Fertigung GmbH & Co. KG
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • SHL Group
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Owen Mumford Limited
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Injex Pharma GmbH
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  11. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 38 market data tables and 32 figures on "Injectable Drug Delivery Market - Global forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.